Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.